Medical management of chronic inflammatory bowel disease

Angus, 1992, Oral fluticasone propionate in active distal ulcerative colitis, Gut, 33, 711, 10.1136/gut.33.5.711 Bicks, 1989, The current status of T-lymphocyte apheresis (TLA) treatment of Crohn's disease, Journal of Clinical Gastroenterology, 11, 136, 10.1097/00004836-198904000-00005 Booth, 1984, Inflammatory bowel disease in childhood, Gut, 25, 188, 10.1136/gut.25.2.188 Brady, 1989, Healing of severe perineal and cutaneous Crohn's disease with hyperbaric oxygen, Gastroenterology, 97, 756, 10.1016/0016-5085(89)90649-5 Brynskov, 1989, A placebo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease, New England Journal of Medicine, 321, 845, 10.1056/NEJM198909283211301 Burke, 1989, Ulcerative colitis: prolonged remission following azathioprine-induced pancytopenia, Journal of Clinical Gastroenterology, 11, 327, 10.1097/00004836-198906000-00017 Calkins, 1989, A meta-analysis of the role of smoking in inflammatory bowel disease, Digestive Diseases and Sciences, 34, 1841, 10.1007/BF01536701 Cooper, 1990, Growth suppression in the Trichuris dysentery syndrome, European Journal of Clinical Nutrition, 44, 285 Crotty, 1992, Inhibition of binding of interferongamma to its receptor by salicylates used in inflammatory bowel disease, Gut, 33, 1353, 10.1136/gut.33.10.1353 Davis, 1990, Surgery for Crohn's disease in childhood—influence of site of disease and operative procedure on outcome, British Journal of Surgery, 77, 891, 10.1002/bjs.1800770816 Derkx, 1993, Tumour-necrosis-factor antibody treatment in Crohn's disease, Lancet, 342, 173, 10.1016/0140-6736(93)91375-V Emerit, 1991, Phase II trial of copper zinc superoxide dismutase (CuZn SOD) in the treatment of Crohn's disease, Free Radical Research Communications, 12–13, 563, 10.3109/10715769109145831 Emmrich, 1991, Treatment of inflammatory bowel disease with anti-CD4 monoclonal antibody, Lancet, 338, 570, 10.1016/0140-6736(91)91133-F Gaffney, 1991, Response to heparin in patients with ulcerative colitis, Lancet, 337, 238, 10.1016/0140-6736(91)92201-C Gendre, 1993, Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: a multicenter placebo-controlled study. The Groupe d'Etudes Therapeutiquesdes Affections Inflammatoires Digestives (GETAID), Gastroenterology, 104, 435, 10.1016/0016-5085(93)90411-5 Greenfield, 1993, Inhibition of leukocyte adhesion molecule upregulation by tumour necrosis factor α: a novel mechanism of action of sulphasalazine, Gut, 34, 252, 10.1136/gut.34.2.252 Grisham, 1992, Prooxidant properties of 5-aminosalicylic acid. Possible mechanism for its adverse side effects, Digestive Diseases and Sciences, 37, 1383, 10.1007/BF01296008 Hanauer, 1993, Rapid closure of Crohn's disease fistulas with continuous intravenous cyclosporin A, American Journal of Gastroenterology, 88, 646 Hawthorne, 1992, Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomized controlled trial, Gut, 33, 922, 10.1136/gut.33.7.922 Hawthorne, 1993, Double blind trial of oral fluticasone propionate v prednisolone in the treatment of active ulcerative colitis, Gut, 34, 125, 10.1136/gut.34.1.125 Hodgson, 1991, Cyclosporin in inflammatory bowel disease, Alimentary Pharmacology and Therapeutics, 5, 343, 10.1111/j.1365-2036.1991.tb00037.x James, 1988, Remission of Crohn's disease after human immunodeficiency virus infection, Gastroenterology, 95, 1667, 10.1016/S0016-5085(88)80094-5 de Kaski, 1991, Fluticasone propionate in Crohn's disease, Gut, 32, 657, 10.1136/gut.32.6.657 Keshavarzian, 1992, Agents capable of eliminating reactive oxygen species: catalase, WR-2721, or Cu(II)2(3,5-DIPS)4 decrease experimental colitis, Digestive Diseases and Sciences, 37, 1866, 10.1007/BF01308081 Kitano, 1992, New treatment of ulcerative colitis with K-76, Diseases of the Colon and Rectum, 35, 560, 10.1007/BF02050536 Klein, 1992, Alteration in glycosaminoglycan metabolism and surface charge on human umbilical vein endothelial cells induced by cytokines, endotoxin andneutrophils, Journal of Cell Science, 102, 821, 10.1242/jcs.102.4.821 Kochar, 1990, Sucralfate enema in ulcerative rectosigmoid lesions, Diseases of the Colon and Rectum, 33, 49, 10.1007/BF02053202 Landi, 1992, Endoscopic monitoring of Crohn's disease treatment: a prospective, randomized clinical trial. The Groupe d'Etudes Therapeutiques des AffectionsInflammatoires Digestives, Gastroenterology, 102, 1647, 10.1016/0016-5085(92)91725-J Langholz, 1992, Treatment of Crohn's disease with fusidic acid: an antibiotic with immunosuppressive properties similar to cyclosporin, Alimentary Pharmacology and Therapeutics, 6, 495, 10.1111/j.1365-2036.1992.tb00563.x Lashner, 1990, Testing nicotine gum for ulcerative colitis patients. Experience with single-patient trials, Digestive Diseases and Sciences, 35, 827, 10.1007/BF01536795 Leonard-Jones, 1981, Azathiaprine and 6-mercapto-purine have a role in the treatment of Crohn's Disease, Digestive Diseases and Sciences, 26, 364, 10.1007/BF01308381 Levin, 1992, Role of oxygen free radicals in the aetiology of pouchitis, Diseases of the Colon and Rectum, 35, 452, 10.1007/BF02049401 Levine, 1992, Intravenous immunoglobulin therapy for active, extensive, and medically refractory idiopathic ulcerative or Crohn's colitis, American Journal of Gastroenterology, 87, 91 Lipson, 1990, Acceleration of linear growth following intestinal resection for Crohn's disease, European Journal of Paediatrics, 149, 687, 10.1007/BF01959522 MacDermott, 1989, Inhibition of antibody secretion by 5-aminosalicylic acid, Gastroenterology, 96, 442, 10.1016/0016-5085(89)91569-2 Mahida, 1991, 5-Aminosalicylic acid is a potent inhibitor of interleukin 1 beta production in organ culture of colonic biopsy specimens from patientswith inflammatory bowel disease, Gut, 32, 50, 10.1136/gut.32.1.50 Malchow, 1984, European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment, Gastroenterology, 86, 249, 10.1016/0016-5085(84)90409-8 Mallett, 1990, Anorexia nervosa complicating inflammatory bowel disease, Archives of Disease in Childhood, 65, 298, 10.1136/adc.65.3.298 Modigliani, 1990, Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives, Gastroenterology, 98, 811, 10.1016/0016-5085(90)90002-I Motley, 1990, Smoking, eicosanoids and ulcerative colitis, Journal of Pharmacy and Pharmacology, 42, 288, 10.1111/j.2042-7158.1990.tb05411.x Murch, 1993, Disruption of sulphated glycosaminoglycans in intestinal inflammation, Lancet, 341, 711, 10.1016/0140-6736(93)90485-Y Nielsen, 1991, Effect of the leukotriene LTD4/LTE4 antagonist, SR 2640, in ulcerative colitis: an open clinical study, Prostaglandins Leukotrienes and Essential Fatty Acids, 42, 181, 10.1016/0952-3278(91)90155-X O'Donnell, 1992, Double blind, controlled trial of 4-amino-salicylic acid and prednisolone enemas in distal ulcerative colitis, Gut, 33, 947, 10.1136/gut.33.7.947 Riley, 1989, A comparison of sucralfate and prednisolone enemas in the treatment of active distal ulcerative colitis, Scandinavian Journal of Gastroenterology, 24, 1014, 10.3109/00365528909089249 Ross, 1993, The role of marine fish oils in the treatment of ulcerative colitis, Nutrition Reviews, 51, 47 Rutgeerts, 1992, Rifabutin and ethambutol do not help recurrent Crohn's disease in the neoterminal ileum, Journal of Clinical Gastroenterology, 15, 24, 10.1097/00004836-199207000-00007 Ryder, 1990, Rectal bismuth subsalicylate as therapy for ulcerative colitis, Alimentary Pharmacology and Therapeutics, 4, 333, 10.1111/j.1365-2036.1990.tb00480.x Salim, 1992, Role of oxygen-derived free radical scavengers in the management of recurrent attacks of ulcerative colitis: a new approach, Journal of Laboratory and Clinical Medicine, 119, 710 Salomon, 1990, Treatment of ulcerative colitis with fish oil n-3-omega-fatty acid: an open trial, Journal of Clinical Gastroenterology, 12, 157, 10.1097/00004836-199004000-00009 Sandborn, 1992, Cyclosporine treatment of inflammatory bowel disease, Mayo Clinic Proceedings, 67, 981, 10.1016/S0025-6196(12)60930-6 Sandborn, 1992, Measurement of colonic tissue cyclosporine concentration in children with severe ulcerative colitis, Journal of Pediatric Gastroenterology and Nutrition, 15, 125, 10.1097/00005176-199208000-00004 Sandborn, 1993, Cyclosporine enemas for treatment—resistant, mildly to moderately active, left-sided ulcerative colitis, American Journal of Gastroenterology, 88, 640 Sanderson, 1987, Remission induced by elemental diet in small bowel Crohn's disease, Archives of Diseases in Childhood, 61, 123, 10.1136/adc.62.2.123 Singleton, 1993, Mesalamine capsules for the treatment of active Crohn's disease: results of a 16-week trial, Gastroenterology, 104, 1293, 10.1016/0016-5085(93)90337-C Sutherland, 1990, Effect of cigarette smoking on recurrence of Crohn's disease, Gastroenterology, 98, 1123, 10.1016/0016-5085(90)90324-T Tamai, 1991, Scavenging effect of 5-aminosalicylic acid on neutrophil-derived oxidants. Possible contribution to the mechanism of action in inflammatory boweldisease, Biochemical Pharmacology, 41, 1001, 10.1016/0006-2952(91)90207-L Tolia, 1992, Sulfasalazine desensitization in children and adolescents with chronic inflammatory bowel disease, American Journal of Gastroenterology, 87, 1029 Treem, 1991, Cyclosporine treatment of severe ulcerative colitis in children, Journal of Pediatrics, 119, 994, 10.1016/S0022-3476(05)83066-5 Villani-Price, 1992, Multiple actions of the leukotriene B4 antagonist SC-41930, Journal of Pharmacology and Experimental Therapeutics, 260, 187 Wakefield, 1989, Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction, Lancet, 334, 1057, 10.1016/S0140-6736(89)91078-7 Werlin, 1977, Severe colitis in children and adolescents: diagnostic course and treatment, Gastroenterology, 73, 828, 10.1016/S0016-5085(19)31792-5